Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations
Ryan Cook, Canyon Foot, Onyebuchi A. Arah, et al.
Addiction Science & Clinical Practice (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Systematic review of applied transportability and generalizability analyses: A landscape analysis
Quang Vuong, Rebecca Metcalfe, Albee Y. Ling, et al.
Annals of Epidemiology (2025)
Open Access | Times Cited: 1
Endogenous opiates and behavior: 2023
Richard J. Bodnar
Peptides (2024) Vol. 179, pp. 171268-171268
Closed Access | Times Cited: 4
A cross‐sectional study of differences in medication for opioid use disorder receipt among pregnant people enrolled in Medicaid in Oregon, United States
Camille C. Cioffi, Ann Martinez Acevedo, Deborah J. Cohen, et al.
Addiction (2025)
Closed Access
Longitudinal Patterns and Predictors of Opioid and Stimulant Use Initiation and Cessation among Female Sex Workers Living with HIV in South Africa
Catherine Schluth, Joseph G. Rosen, Mfezi Mcingana, et al.
Drug and Alcohol Dependence (2025) Vol. 269, pp. 112593-112593
Closed Access
The Effects of Psychostimulant Prescription on Opioid Use Disorder Among People with Co-Occurring Adhd
Mohammad Yaseliani, Youngsuhk Jo, L. Lindo, et al.
(2025)
Closed Access
Reconsidering the usefulness of long-term high-dose buprenorphine
Lakshit Jain, Thomas W. Meeks, Christopher K. Blazes
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances
Felipe Castillo, Mei‐Chen Hu, Ying Liu, et al.
Drug and Alcohol Dependence (2023) Vol. 251, pp. 110926-110926
Open Access | Times Cited: 4
Optimizing real-world benefit and risk of new psychedelic medications: the need for innovative postmarket surveillance
Joshua C. Black, Andrew A. Monte, Nabarun Dasgupta, et al.
Nature Mental Health (2024) Vol. 2, Iss. 5, pp. 469-477
Closed Access | Times Cited: 1
Use of transportability methods for real-world evidence generation: a review of current applications
Natalie S. Levy, Patrick J. Arena, Thomas Jemielita, et al.
Journal of Comparative Effectiveness Research (2024)
Open Access | Times Cited: 1
Respiratory Depression Associated with Opioids: A Narrative Review
Mellar P. Davis, Sandra DiScala, Amy L. Davis
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 11, pp. 1438-1450
Closed Access | Times Cited: 1
Dynamics of prescribing and accessing medications for opioid use disorder: a community-based systems analysis
Tianna Herman, Zeynep Hasgul, Tse Yang Lim, et al.
Addiction Research & Theory (2024), pp. 1-12
Closed Access | Times Cited: 1
Stimulant Drugs and Stimulant Use Disorder
Wenyu Song, Aurélien Simona, Ping Zhang, et al.
Anesthesiology Clinics (2023) Vol. 42, Iss. 1, pp. 103-115
Closed Access | Times Cited: 2
Page 1

Scroll to top